Hemodialysis Therapy Market - 2023-2031

July 2025 | 210 pages | ID: H0F58043E73BEN
DataM Intelligence

Abstracts

The Hemodialysis Therapy Market was valued at US$ 13.03 billion in 2023 and is anticipated to reach US$ 19.81 billion by 2031, at a CAGR of 0.05 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Hemodialysis Therapy Market.

This report delivers a comprehensive overview of the Hemodialysis Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemodialysis Therapy Market. The Hemodialysis Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

Hemodialysis Therapy Market Scope:

By Product Type

• Hemodialysis Machines
• Dialyzers
• Bloodline Systems and Tubing Sets
• Concentrates and Solutions
• Vascular Access Devices
• Hemodialysis Filters and Cartridges

By Modality

• Conventional Hemodialysis (HD)
• Nocturnal Hemodialysis
• Short Daily Hemodialysis
• Home Hemodialysis (HHD)

By Dialysis Type

• In-Center Dialysis
• Home Dialysis

By Patient Age Group

• Pediatric Patients
• Adult Patients
• Geriatric Patients

By Technology

• High-Performance Hemodialysis (HPHD)
• Expanded Hemodialysis (HDx)
• Hemodiafiltration (HDF)
• Conventional Hemodialysis

By End-User

• Hospitals
• Dialysis Centers
• Homecare Settings
• Specialty Clinics

Key Players

• Fresenius Medical Care AG & Co. KGaA
• Baxter
• Nikkiso Co., Ltd.
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Nipro Corporation
• Rockwell Medical, Inc.
• Medtronic plc
• Dialife SA
• AWAK Technologies

Major Highlights

This report delivers a comprehensive overview of the Hemodialysis Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemodialysis Therapy Market. The Hemodialysis Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Dialysis Type
3.4. Snippet by Patient Age Group
3.5. Snippet by Technology
3.6. Snippet by End-User
3.7. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Prevalence of Chronic Kidney Diseases
  4.1.2. Restraints
  4.1.3. Complications Linked With Procedure
  4.1.4. Lack of Awareness
  4.1.5. Opportunity
  4.1.6. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. BY PRODUCT TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  6.1.2. Market Attractiveness Index, By Product Type
6.2. Hemodialysis Machines*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Dialyzers
6.4. Bloodline Systems and Tubing Sets
6.5. Concentrates and Solutions
6.6. Vascular Access Devices
6.7. Hemodialysis Filters and Cartridges

7. BY MODALITY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  7.1.2. Market Attractiveness Index, By Modality
7.2. Conventional Hemodialysis (HD)*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nocturnal Hemodialysis
7.4. Short Daily Hemodialysis
7.5. Home Hemodialysis (HHD)

8. BY DIALYSIS TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  8.1.2. Market Attractiveness Index, By Dialysis Type
8.2. In-Center Dialysis*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Home Dialysis

9. BY PATIENT AGE GROUP

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
9.2. Market Attractiveness Index, By Patient Age Group
9.3. Pediatric Patients*
  9.3.1. Introduction
  9.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.4. Adult Patients
9.5. Geriatric Patients

10. BY TECHNOLOGY

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.1.2. Market Attractiveness Index, By Technology
10.2. High-Performance Hemodialysis (HPHD)*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Expanded Hemodialysis (HDx)
10.4. Hemodiafiltration (HDF)
10.5. Conventional Hemodialysis

11. BY END-USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Dialysis Centers
11.4. Homecare Settings
11.5. Specialty Clinics

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.9.1. U.S.
    12.2.9.2. Canada
    12.2.9.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.9.1. Germany
    12.3.9.2. UK
    12.3.9.3. France
    12.3.9.4. Italy
    12.3.9.5. Spain
    12.3.9.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.9.1. Brazil
    12.4.9.2. Argentina
    12.4.9.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.9.1. China
    12.5.9.2. India
    12.5.9.3. Japan
    12.5.9.4. South Korea
    12.5.9.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dialysis Type
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Age Group
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. Fresenius Medical Care AG & Co. KGaA*
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Financial Overview
  14.1.4. Key Developments
14.2. Baxter
14.3. Nikkiso Co., Ltd.
14.4. B. Braun Melsungen AG
14.5. Asahi Kasei Corporation
14.6. Nipro Corporation
14.7. Rockwell Medical, Inc.
14.8. Medtronic plc
14.9. Dialife SA
14.10. AWAK Technologies (*LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us